The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...

The US Food and Drug Administration (FDA) approved a new oral antibiotic to treat uncomplicated urinary tract infections ...

The US Food and Drug Administration has approved a new oral antibiotic for treatment of uncomplicated urinary tract ...

The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...

A mild UTI may last days or under a week. These are sometimes called uncomplicated UTIs. Learn how long a complicated UTI ...

The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

Nonantibiotic prophylactic options for UTIs such as methenamine hippurate remain significantly underutilized, especially for ...

Urinary tract infections are common, especially, though not exclusively, in women, and the risk generally increases with age.

Veterinarians should become familiar with new definitions and recommendations for managing urinary tract infections in dogs ...

Orlynvah is the first oral penem approved in the U.S. and Iterum Therapeutics’ first FDA-approved product. CEO Corey Fishman ...

Doctors prescribe the drugs more readily than before, including in cases where they might not be necessary ... coli bacteria and certain types of salmonella (hello, food poisoning) has increased by 15 ...